Patents by Inventor Irit AVIVI

Irit AVIVI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220204928
    Abstract: The present invention provides extracellular vesicles (EVs) derived from T-cells expressing chimeric antigen receptors (CAR) specifically activated with an antigen to which the CAR bind specifically, pharmaceutical compositions comprising these vesicles as well as their use in treating cancer. In particular the present invention exemplifies EVs derived from activated T-cells expressing CAR that bind specifically to HER2 cancer antigen, pharmaceutical composition comprising these EVs and their use in treating a cancer overexpressing HER2, such as ovarian cancer and breast cancer.
    Type: Application
    Filed: April 16, 2020
    Publication date: June 30, 2022
    Inventors: Anat AHARON, Anat GLOBERSON LEVIN, Irit AVIVI, Galit HORN, Tova WAKS, Zelig ESHHAR